- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat ; volume:15 ; number:1 ; day:27 ; month:5 ; year:2014 ; pages:1-8 ; date:12.2014
BMC pharmacology & toxicology ; 15, Heft 1 (27.5.2014), 1-8, 12.2014
- Creator
-
Hole, Lisa Drange
- Contributor
-
Larsen, Terje Hjalmar
Fossan, Kjell Ove
Limé, Fredrik
SchjøTt, Jan
SpringerLink (Online service)
- DOI
-
10.1186/2050-6511-15-28
- URN
-
urn:nbn:de:1111-2016071827849
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hole, Lisa Drange
- Larsen, Terje Hjalmar
- Fossan, Kjell Ove
- Limé, Fredrik
- SchjøTt, Jan
- SpringerLink (Online service)
Other Objects (12)
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart
Glycine protects against doxorubicin-induced heart toxicity in mice
Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart
Glycine protects against doxorubicin-induced heart toxicity in mice
Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart
Glycine protects against doxorubicin-induced heart toxicity in mice
Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity